Hook
On August 17, 2024, Zhibao Technology announced it had completed a PIPE financing that is anything but standard. The consideration: 2,380 Bitcoin. Not dollars. Not stablecoins. Raw, unadulterated BTC. This is not a protocol upgrade. This is a financial engineering experiment on a public company’s balance sheet. The move is being hailed by some as a bold bet on Bitcoin as a reserve asset, but beneath the surface, the structure reveals a complex web of dilution, regulatory ambiguity, and risk that most market participants are ignoring. I’ve audited dozens of PIPE deals over the past decade, and this one stands out for its audacity—and its potential pitfalls.
Context
Zhibao Technology Inc. is a Shanghai-based insurtech firm that provides digital insurance solutions. It is listed on a U.S. exchange (likely NASDAQ or OTC) and files with the SEC. On August 17, it disclosed via Form 6-K that it had completed a private placement of 442,000,000 units at $0.35 per unit, with each unit consisting of one share of Class A common stock and one warrant exercisable at $0.35 for two years. The total gross proceeds: approximately $154.7 million—but instead of cash, the company accepted 2,380 Bitcoin at a reference price of $65,000 per BTC. The BTC has been transferred to the company’s wallet. This is not a crypto-native firm; it is a traditional insurance technology company adopting a Bitcoin treasury strategy reminiscent of MicroStrategy, but with a much smaller scale and a far more complex capital structure.
Core: Technical Feasibility and Narrative Mechanics
First, the technical feasibility. Zhibao is not building a blockchain protocol; it is executing a financial transaction. The PIPE structure itself is a well-worn tool in traditional finance, but using Bitcoin as consideration introduces three critical risks: custody, valuation, and dilution.
Custody Risk: The company now holds 2,380 BTC on its balance sheet, but the announcement provides zero details on custody. Cold wallet? Multi-sig? Third-party custodian? Without this information, we cannot assess the security of the asset. In 2022, I led a crisis response for a DeFi project that lost $50 million due to a private key compromise. The lack of transparency here is a red flag. The company’s board likely has a custody plan, but the absence of disclosure is a failure of risk communication. Narrative is the new liquidity, but trust is the new collateral.
Valuation Risk: The reference price of $65,000 was set in late July when the term sheet was signed. By mid-August, Bitcoin had traded as low as $58,000. If the actual market price at delivery was lower, the investors effectively purchased equity at a discount to the stated $0.35 per unit. Conversely, if BTC was above $65,000, the company received a premium. This asymmetry is not disclosed. The market is left to guess. Based on my experience auditing ICOs in 2017, such valuation gaps often lead to disputes or hidden losses.
Dilution Mechanism: The PIPE issued 395.7 million shares immediately, with an additional 46.3 million shares pending shareholder approval to increase authorized capital. That’s 442 million new shares. On top of that, each unit includes a warrant exercisable for two years. If all warrants are exercised, the company could issue another 442 million shares, bringing the total potential dilution to 884 million shares. The original share count is not disclosed, but if Zhibao had a small float—say 50 million shares—the dilution would be staggering. Existing shareholders would see their ownership stake reduced by over 90%. This is not a Bitcoin treasury play; it is a capital raise disguised as a crypto adoption story.
Now, the narrative mechanics. Zhibao is tapping into the “Bitcoin as corporate reserve” narrative popularized by MicroStrategy. But MicroStrategy’s strategy is backed by a clear financial model: they issue debt or equity to buy BTC, and their stock trades as a leveraged BTC proxy. Zhibao’s structure is different. They are not buying BTC with cash; they are issuing equity in exchange for BTC. The investors are converting their BTC exposure into Zhibao equity. This is a swap, not a purchase. The net effect is that the company’s asset base now includes BTC, but its liability side is bloated with new shares and warrants. Hype is cheap. Strategy is expensive.
Data supports the concern. The initial plan was to raise 3,500 BTC, but the final deal closed at 2,380 BTC—a 32% reduction. In private placements, such a reduction signals weak demand or a renegotiation of terms. The investors likely pushed back on valuation or the company’s fundamentals. The 46.3 million shares “pending approval” are essentially free shares that investors will receive without additional payment—a sweetener that further dilutes existing holders. This is not a sign of strength.
Contrarian Angle: The Hidden Bull Case and the Real Blind Spots
The mainstream narrative is that Zhibao is a “crypto-friendly” company that will benefit from Bitcoin’s appreciation. The contrarian view is that this deal is a lifeline for a company struggling to raise cash in traditional markets. Insurance tech is a capital-intensive sector with thin margins. By accepting BTC, Zhibao may have accessed a new pool of investors—crypto-native funds or OTC desks—who were willing to part with BTC rather than dollars. But these investors are not passive; they now hold a huge equity stake and will likely seek to exit via the public market. The free shares and warrants create a massive overhang.
Another blind spot: the regulatory ambiguity. Zhibao is headquartered in Shanghai, China, where cryptocurrency trading is effectively banned. The company’s U.S. listing subjects it to SEC oversight, but its operations in China could attract scrutiny from Chinese regulators. The 6-K filing is a compliance step, but it does not address how the company will manage the BTC under Chinese law. If the People’s Bank of China decides to crack down on offshore holdings, Zhibao could face asset seizure or forced divestiture. I have seen this play out before—in 2021, a Chinese-listed company that held crypto faced a regulatory investigation that wiped out 80% of its market cap.
Furthermore, the lack of an independent audit for the BTC holding is a risk. No auditor has verified the wallet address, the private key control, or the HTLC (if any). The company’s financial statements will need to account for BTC under U.S. GAAP, which treats crypto as indefinite-lived intangible assets—subject to impairment charges but not upward revaluation. This accounting treatment could depress book value over time. The warrants are also complex equity derivatives that require fair value measurement. The cost of compliance and disclosure will be significant.
Takeaway: The Next Narrative
Zhibao’s PIPE is a microcosm of a larger trend: traditional companies using Bitcoin as a funding tool rather than as a speculative asset. But the costs are high, and the risks are underappreciated. The success of this strategy hinges on three things: the shareholder vote to approve the additional shares, the company’s ability to manage custody and regulatory risk, and the price of Bitcoin in the next two years. If BTC rallies, the dilution may be offset by the asset appreciation. If it stagnates, shareholders face a multi-year overhang.